Investment
Features
FeesSafety
Academy
More
Pluang+

Compare National Beverage Corp. (FIZZ) vs 22nd Century Group Inc (XXII) Price & Performance

National Beverage Corp.Trade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

National Beverage Corp. vs 22nd Century Group Inc — how do they compare? National Beverage Corp. trades at $30.65 (market cap $2.89B), while 22nd Century Group Inc trades at $0.84 (market cap $621.67K). The key difference: National Beverage Corp. is far larger — about 4648.8× 22nd Century Group Inc's market cap, and National Beverage Corp. is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold National Beverage Corp. for 33 Days and 22nd Century Group Inc for 32 Days on average.

FIZZXXII
Market Cap
$2.89B$621.67K
Volume
553,95045,625
Sector
Consumer StaplesConsumer Staples
52-Week High
$37.73$483.00
52-Week Low
$29.20$0.80
Typical Hold Time
33 Days32 Days
Enterprise Value
$2.84B-$3.69M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

National Beverage Corp.

National Beverage Corp. (FIZZ) trades at $30.36, up 2.57% today, showing mixed signals with a bullish technical outlook but bearish analyst sentiment. The stock faces margin pressure with recent earnings misses and declining revenue growth, though profitability metrics remain strong with 14.81% net margin and 40.13% ROE. Recent news highlights institutional buying and a $3.25 special dividend payment.

FIZZ presents a cautious investment case with strong profitability offset by growth challenges. The company's high ROE and solid margins provide fundamental support, but consecutive earnings misses and tariff-related margin compression create near-term headwinds. Analyst consensus leans bearish with 50% sell ratings, suggesting limited upside potential despite technical strength.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIZZ

No sentiment data available yet.

XXII
100% Buy0% Sell
Avg holding period · 32 Days

About National Beverage Corp.

National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.

Read more on FIZZ →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →